TSX:BLX • CA09950M3003
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BORALEX INC -A (BLX.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-02 | TD Cowen | Maintains | Buy -> Buy |
| 2022-12-15 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-11-21 | RBC Royalbank | Downgrade | Sector Perform |
| 2022-11-21 | National Bank of Canada Financial | Downgrade | Outperform |
| 2022-11-21 | BMO Financial | Downgrade | |
| 2022-11-21 | Scotiabank Capital | Maintains | Outperform |
| 2022-11-21 | Credit Suisse | Downgrade | |
| 2022-11-10 | BMO Financial | Upgrade | Outperform |
| 2022-11-10 | TD Research | Downgrade | Buy |
| 2022-11-10 | Scotiabank Capital | Downgrade | Outperform |
| 2022-10-25 | Credit Suisse | Downgrade | Neutral |
| 2022-10-20 | Scotiabank Capital | Downgrade | Strong Buy |
| 2022-10-18 | CIBC Capital Markets | Downgrade | |
| 2022-10-07 | National Bank of Canada Financial | Downgrade | Outperform |
| 2022-09-27 | Credit Suisse | Upgrade | Buy |
| 2022-09-20 | BMO Financial | Upgrade | |
| 2022-09-16 | CIBC Capital Markets | Upgrade | |
| 2022-08-24 | Credit Suisse | Upgrade | |
| 2022-08-04 | Raymond James Capital | Upgrade | Outperform |
| 2022-08-04 | RBC Royalbank | Upgrade | Sector Perform |
| 2022-08-04 | National Bank of Canada Financial | Upgrade | Outperform |
| 2022-08-04 | BMO Financial | Upgrade | Outperform |
| 2022-08-04 | TD Research | Upgrade | Buy |
| 2022-08-04 | CIBC Capital Markets | Upgrade | Outperform |
| 2022-08-04 | Scotiabank Capital | Upgrade | Outperform |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.022B 22.25% | 853M -16.54% | 849M -0.47% | 997.53M 17.49% | 1.03B 3.26% | 1.236B 20.00% | N/A | N/A | |
| EBITDA YoY % growth | 539M 9.55% | 528M -2.04% | 504M -4.55% | 747.99M 48.41% | 771.99M 3.21% | 818.31M 6.00% | 966.17M 18.07% | 1.043B 7.95% | |
| EBIT YoY % growth | 246M 24.87% | 231M -6.10% | 183M -20.78% | 343.95M 87.95% | 359.51M 4.52% | 452.66M 25.91% | 469.12M 3.64% | N/A | |
| Operating Margin | 24.07% | 27.08% | 21.55% | 34.48% | 34.90% | 36.62% | N/A | N/A | |
| EPS YoY % growth | 0.93 220.69% | 0.68 -26.88% | 0.06 -91.18% | 1.10 1,728.52% | 1.13 2.84% | 1.41 25.02% | 1.92 36.35% | N/A |
All data in CAD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | 0.57 95.03% | 0.19 286.85% | -0.07 72.81% | 0.84 544.85% |
| Revenue Q2Q % growth | 277.75M 22.90% | 214.12M 15.74% | N/A | N/A |
| EBITDA Q2Q % growth | 204.95M 41.34% | 161.84M -13.91% | N/A | N/A |
| EBIT Q2Q % growth | 73.73M 3.85% | 62.62M 78.91% | N/A | N/A |
All data in CAD
12 analysts have analysed BLX.CA and the average price target is 35.59 CAD. This implies a price increase of 31.56% is expected in the next year compared to the current price of 27.05.
BORALEX INC -A (BLX.CA) will report earnings on 2026-05-12.
The consensus EPS estimate for the next earnings of BORALEX INC -A (BLX.CA) is 0.57 CAD and the consensus revenue estimate is 277.75M CAD.
The expected long term growth rate for BORALEX INC -A (BLX.CA) is 11.04%.